CPT® 81523, Under Multianalyte Assays with Algorithmic Analyses
The Current Procedural Terminology (CPT®) code 81523 as maintained by American Medical Association, is a medical procedural code under the range - Multianalyte Assays with Algorithmic Analyses.
Subscribe to Codify by AAPC and get the code details in a flash.
Tabs
Summary
Code 81523 describes a next–generation sequence (NGS) analysis using a formalin–fixed paraffin–embedded (FFPE) breast tumor tissue specimen. The test is a Multianalyte Assay with Algorithmic Analysis (MAAA) that evaluates mRNA gene expression profile of 70 content genes with 31 housekeeping genes, and uses an algorithmic analysis of the results plus patient data to report an index related to the risk of breast cancer distant metastasis (spread).
For clinical responsibility, terminology, tips and additional info
start codify free trial.
View any code changes for 2024 as well as historical information on code creation and revision.
Tabs
Combat the #1 denial reason - mismatched CPT-ICD-9 codes - with top Medicare carrier and private payer accepted diagnoses for the chosen CPT® code.
View the CPT® code's corresponding procedural code and DRG. In a click, check the DRG's IPPS allowable, length of stay, and more. To plug inpatient facility revenue drains, subscribe to DRG Coder today.
Crosswalk to an anesthesia code and its base units, and calculate payments in a snap! Subscribe to Anesthesia Coder today.
View matching HCPCS Level II codes and their definitions.
Read a CPT® Assistant article by subscribing to Code Connect Today!
Search across Medicare Manuals, Transmittals, and more. For FREE Trial, register now!